• All Courts
  • Federal Courts
  • Bankruptcies
  • PTAB
  • ITC
Track Search
Export
Download All
Displaying 549-563 of 645 results

1506 Exhibit: PUBLIC VERSION Deposition Transcript of Dr Yoshiyuki Tatsumi

Document IPR2017-00190, No. 1506-2 Exhibit - PUBLIC VERSION Deposition Transcript of Dr Yoshiyuki Tatsumi (P.T.A.B. Nov. 1, 2017)

cite Cite Document

1672 Exhibit: Declaration of Lisa N Phillips in Support of Petitioners¿¿¿ Response to ...

Document IPR2017-00190, No. 1672 Exhibit - Declaration of Lisa N Phillips in Support of Petitioners¿¿¿ Response to Patent Owner¿¿¿s Objections to Evidence Served November 22, 2017 (P.T.A.B. Jan. 5, 20...

cite Cite Document

1512 Exhibit: Dermatologic conditions of the foot

Document IPR2017-00190, No. 1512 Exhibit - Dermatologic conditions of the foot (P.T.A.B. Nov. 1, 2017)

cite Cite Document

2203 Exhibit: Kaken Exhibit 2203

Document IPR2017-00190, No. 2203 Exhibit - Kaken Exhibit 2203 (P.T.A.B. Jul. 27, 2018)

cite Cite Document

2112 Exhibit: Kaken Exhibit 2112

Document IPR2017-00190, No. 2112 Exhibit - Kaken Exhibit 2112 (P.T.A.B. Jan. 5, 2018)

cite Cite Document

2111 Exhibit: Kaken Exhibit 2111

Document IPR2017-00190, No. 2111 Exhibit - Kaken Exhibit 2111 (P.T.A.B. Jan. 5, 2018)

cite Cite Document

1626 Exhibit: Exhibit 1626a ¿¿¿Copay Programs¿¿¿ Increased Value to Manufacturer...

Document IPR2017-00190, No. 1626 Exhibit - Exhibit 1626a ¿¿¿Copay Programs¿¿¿ Increased Value to Manufacturers is Matched by Rising Criticism,¿¿¿ S Shelly, Pharmaceutical Commerce, 91 1 32 Januar...

cite Cite Document

1619 Exhibit: Exhibit 1619a ¿¿¿Physicians Pharmaceutical Sales Representatives in...

Document IPR2017-00190, No. 1619 Exhibit - Exhibit 1619a ¿¿¿Physicians Pharmaceutical Sales Representatives interactions and Conflict of Interest Challenges and Solutions,¿¿¿ AR Patwardhan, The Jou...

cite Cite Document

1668 Exhibit: Declaration of Aydin H Harston in Support of Supplemental Evidence ...

Document IPR2017-00190, No. 1668 Exhibit - Declaration of Aydin H Harston in Support of Supplemental Evidence Served May 30, 2017, with attached exhibits (P.T.A.B. Jan. 5, 2018)

cite Cite Document

1507 Exhibit: PUBLIC VERSION Deposition Transcript of Vincent A Thomas

Document IPR2017-00190, No. 1507-2 Exhibit - PUBLIC VERSION Deposition Transcript of Vincent A Thomas (P.T.A.B. Nov. 1, 2017)

cite Cite Document

1603 Exhibit: Exhibit 1603a Valeant Pharmaceuticals International, Inc, US Securit...

Document IPR2017-00190, No. 1603 Exhibit - Exhibit 1603a Valeant Pharmaceuticals International, Inc, US Securities and Exchange Commission Form 10 K, for the Fiscal Year Ended December 31, 2013...

cite Cite Document

2202 Exhibit: Kaken Exhibit 2202

Document IPR2017-00190, No. 2202 Exhibit - Kaken Exhibit 2202 (P.T.A.B. Jan. 5, 2018)

cite Cite Document

3001 Exhibit: Ex 3001

Document IPR2017-00190, No. 3001 Exhibit - Ex 3001 (P.T.A.B. Dec. 10, 2018)

cite Cite Document

1516 Exhibit: Label for Diflucan¿¿ fluconazole tablets, Pfizer Inc, NDA 19 949

Document IPR2017-00190, No. 1516 Exhibit - Label for Diflucan¿¿ fluconazole tablets, Pfizer Inc, NDA 19 949 (P.T.A.B. Nov. 1, 2017)

cite Cite Document

1005 Exhibit: Declaration of Kenneth Walters

Document IPR2017-00190, No. 1005 Exhibit - Declaration of Kenneth Walters (P.T.A.B. Nov. 2, 2016)

cite Cite Document
<< 1 2 3 4 5 ... 37 38 39 40 41 ... >>